Breaking News Instant updates and real-time market news.

WBA

Walgreens Boots Alliance

$58.05

1.21 (2.13%)

, AAPL

Apple

$225.65

8.08 (3.71%)

07:38
09/12/19
09/12
07:38
09/12/19
07:38

Walgreens Boots Alliance to offer 3% daily cash with Apple Card, Pay purchases

Walgreens (WBA) customers will receive 3% Daily Cash when they use Apple (AAPL) Card with Apple Pay on eligible purchases, including prescriptions, made in Walgreens and Duane Reade stores and for purchases made on the Walgreens app and on walgreens.com. Walgreens is the only retail pharmacy to offer 3% Daily Cash on Apple Card with Apple Pay purchases. Daily Cash is Apple Card's rewards program that gives back a percentage of every purchase as cash on customers' Apple Cash card each day. This means that when customers and patients use their Apple Card with Apple Pay, they'll receive 3% cash back on all eligible health, beauty, personal care, household and seasonal products they purchase at Walgreens or Duane Reade, including medicines and prescriptions. In addition to offering 3% Daily Cash, Walgreens will also expand the number of stores carrying Apple accessories, including lightning cables, EarPods and iPhone cases, to 2,600 stores chainwide. The offer begin on September 13.

WBA

Walgreens Boots Alliance

$58.05

1.21 (2.13%)

AAPL

Apple

$225.65

8.08 (3.71%)

WBA Walgreens Boots Alliance
$58.05

1.21 (2.13%)

06/28/19
FBCO
06/28/19
DOWNGRADE
Target $60
FBCO
Neutral
Walgreens Boots Alliance assumed at Neutral from Outperform at Credit Suisse
Credit Suisse analyst A.J. Rice assumed coverage of Walgreens Boots Alliance with a Neutral rating, down from the firm's prior Outperform rating, and set a $60 price target on the stock, down from the firm's prior $70 target. Rice noted that Walgreens cut its guidance for FY19 and reduced its long-term EPS growth target to the mid-to-high single digits and said he would want to see clear indications that visibility on earnings growth is improving before considering raising his rating.
06/28/19
06/28/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. 1. Walgreens Boots Alliance (WBA) downgraded to Neutral from Outperform at Credit Suisse with analyst A.J. Rice saying Walgreens cut its guidance for FY19 and reduced its long-term EPS growth target to the mid-to-high single digits and said he would want to see clear indications that visibility on earnings growth is improving before considering raising his rating. 2. Biogen (BIIB) downgraded to Neutral from Overweight at Piper Jaffray with analyst Christopher Raymond saying Piper's new neurologist survey data from Spherix Global Insights "spells bad news for both Tecfidera and Tysabri in the near and longer term." 3. Live Nation (LYV) downgraded to Sell from Neutral at Citi with analyst Jason Bazinet saying he still likes the company's growth prospects and "consistent" operating performance. 4. Arrowhead (ARWR) downgraded to Neutral from Overweight at Cantor Fitzgerald with analyst Elemer Piros saying he views the stock as fairly valued. 5. Darden (DRI) downgraded to Equal Weight from Overweight at Stephens with analyst Will Slabaugh citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/31/19
PIPR
07/31/19
NO CHANGE
Target $182
PIPR
Overweight
DexCom price target raised to $182 from $173 at Piper Jaffray
Piper Jaffray analyst JP Kim raised his price target on DexCom (DXCM) to $182 and kept his Overweight rating after its "solid" Q2 results and raised guidance. driven by the 41% U.S. revenue growth in spite of the tougher comp. The analyst is positive on the pharmacy coverage unlocking more type 2 diabetes patients, manufacturing lines preparing for the G7 Continuous Glucose Monitoring system, and its "direct to Apple (AAPL) Watch"compatibility, as well as the company's Walgreens (WBA) partnership, even though he sees tougher annual comps and a Medicare pricing headwind in Q4.
09/11/19
DBAB
09/11/19
INITIATION
Target $53
DBAB
Sell
Walgreens Boots Alliance initiated with a Sell at Deutsche Bank
Deutsche Bank analyst George Hill initiated Walgreens Boots Alliance with a Sell rating and a price target of $53 as part of a broader research note on Healthcare Technology & Services. The analyst warns that the company's stand-alone pharmacy business strategy will face "unrelenting competitive and reimbursement pressure", which will likely yield negative earnings revisions. Hill adds that the current "punitive" multiple on the stock is warranted.
AAPL Apple
$225.65

8.08 (3.71%)

09/11/19
MAXM
09/11/19
NO CHANGE
Target $204
MAXM
Hold
Apple price target lowered to $204 from $211 at Maxim
Maxim analyst Nehal Chokshi lowered his price target on Apple to $204 after its Special Event presentation, saying the company's announcements of new iPhones and Watch models were all in-line with expectations. The analyst also states that the Apple TV+ subscription terms were 2-times lowers than his estimate and should weigh on Apple's gross margins. Chokshi keeps his Hold rating on Apple.
09/11/19
JPMS
09/11/19
NO CHANGE
JPMS
Overweight
Apple TV+ pricing a positive catalyst for adoption, says JPMorgan
JPMorgan analyst Samik Chatterjee came out of Apple's (AAPL) event yesterday "largely positive," believing lowered pricing of the iPhone 11 relative to the XR could act as a positive driver for volumes in the entry level premium smartphone segment. Further, the analyst says "favorable pricing" for Apple TV+ and Apple Arcade makes him positive on the potential ramp of the new services. Apple TV+'s monthly subscription price of $4.99 is "quite attractive" relative to competitive services, which should be a positive catalyst for adoption as Apple scales up its original content over time to compete with Netflix (NFLX), Amazon's (AMZN) Prime Video and Disney (DIS), among others, Chatterjee told investors earlier in a research note. He kept an Overweight rating on Apple shares.
09/12/19
IMPC
09/12/19
NO CHANGE
Target $451
IMPC
Outperform
Apple TV pricing adds pressure to Netflix and Disney, says Imperial Capital
The $4.99 monthly price of Apple's (AAPL) TV+ adds pressure to both Netflix (NFLX) and Disney (DIS), Imperial Capital analyst David Miller tells investors in a research note. The price point took most analysts by surprise, as $4.99 is "far less" than what had been previously estimated going in to Apple's presentation, which was somewhere around the $9.00 level, according to Miller. In addition, while Apple's content lineup is not nearly as robust as that offered currently by Netflix , or what will be offered by Disney+, its lineup looked "fairly impressive," headlined by talent such as Jennifer Aniston, Samuel L. Jackson, Ron Moore, Aaron Paul, Oprah Winfrey, Octavia Spencer, and M. Night Shyamalan, Miller contends. However, he believes the market is too focused on price points rather than the "value" for that said price point. The analyst keeps an Outperform rating on Netflix shares with a $451 price target.
09/12/19
FBCO
09/12/19
NO CHANGE
Target $209
FBCO
Neutral
August China shipments dip ahead of Apple iPhone 11 launch, says Credit Suisse
Credit Suisse analyst Matthew Cabral says that Apple iPhone shipments in China fell 19.5% year over year in the month of August per MIIT "non-Android" data, worse than the 2.8% year over year drop in the broader Chinese smartphone market. But looking quarter-to-date, Q3 is up 5.2% year over year, which is a significant improvement versus the difficult start to the year and is tracking well toward Apple's above seasonal September guidance, he contends. The analyst believes the introduction of a triple-camera system on the Pro/Pro Max and the RMB700 price cut should help demand within China at the margin. However, Cabral views this year's feature upgrades as more incremental in nature and thinks they are unlikely to reverse the ongoing extension of replacement cycles, especially without a 5G iPhone until the second half of 2020. He reiterates a Neutral rating and $209 price target.

TODAY'S FREE FLY STORIES

MRAM

Everspin Technologies

$6.52

-0.09 (-1.36%)

12:12
09/20/19
09/20
12:12
09/20/19
12:12
Conference/Events
Everspin Technologies management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 12

    Nov

SAIC

SAIC

$84.64

0.76 (0.91%)

12:11
09/20/19
09/20
12:11
09/20/19
12:11
Recommendations
SAIC analyst commentary  »

SAIC recompete bid on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALNY

Alnylam

$86.18

1.5 (1.77%)

12:11
09/20/19
09/20
12:11
09/20/19
12:11
Conference/Events
Alnylam management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 02

    Oct

  • 04

    Feb

SNPS

Synopsys

$137.26

0.09 (0.07%)

12:10
09/20/19
09/20
12:10
09/20/19
12:10
Conference/Events
Synopsys management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

TYL

Tyler Technologies

$259.35

-0.22 (-0.08%)

12:10
09/20/19
09/20
12:10
09/20/19
12:10
Conference/Events
Tyler Technologies management to meet with JMP Securities »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

AAPL

Apple

$220.96

0.05 (0.02%)

, MCD

McDonald's

$210.55

-0.01 (-0.00%)

12:02
09/20/19
09/20
12:02
09/20/19
12:02
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks are mixed at…

AAPL

Apple

$220.96

0.05 (0.02%)

MCD

McDonald's

$210.55

-0.01 (-0.00%)

FB

Facebook

$190.17

0.02 (0.01%)

MDR

McDermott

$2.70

1.12 (70.89%)

CRC

California Resources

$11.86

1.96 (19.80%)

ROKU

Roku

$114.30

-19.41 (-14.52%)

W

Wayfair

$123.39

-5.275 (-4.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 23

    Sep

  • 24

    Sep

  • 27

    Oct

SCS

Steelcase

$18.34

1.57 (9.36%)

12:00
09/20/19
09/20
12:00
09/20/19
12:00
Hot Stocks
Steelcase rises 9.6% »

Steelcase is up 9.6%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 15

    Oct

  • 16

    Oct

IBN

ICICI Bank

$11.88

1.11 (10.31%)

12:00
09/20/19
09/20
12:00
09/20/19
12:00
Hot Stocks
ICICI Bank rises 10.2% »

ICICI Bank is up 10.2%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRC

California Resources

$11.75

1.85 (18.69%)

12:00
09/20/19
09/20
12:00
09/20/19
12:00
Hot Stocks
California Resources rises 18.8% »

California Resources is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNY

Sanofi

$45.72

0.83 (1.85%)

11:54
09/20/19
09/20
11:54
09/20/19
11:54
Upgrade
Sanofi rating change  »

Morgan Stanley upgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 27

    Sep

  • 02

    Oct

TSLA

Tesla

$242.92

-3.59 (-1.46%)

11:50
09/20/19
09/20
11:50
09/20/19
11:50
Options
Bearish Dec put spread collar in Tesla opened for a small debit »

Bearish Dec put spread…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

SNY

Sanofi

$45.61

0.72 (1.60%)

11:46
09/20/19
09/20
11:46
09/20/19
11:46
Upgrade
Sanofi rating change  »

Sanofi upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 27

    Sep

  • 02

    Oct

CRZBY

Commerzbank

$0.00

(0.00%)

11:46
09/20/19
09/20
11:46
09/20/19
11:46
Hot Stocks
Commerzbank develops draft of new strategy, to cut 4,300 jobs »

Commerzbank announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHHBY

Roche

$0.00

(0.00%)

11:45
09/20/19
09/20
11:45
09/20/19
11:45
Hot Stocks
Roche reports FDA approves cobas Babesia test »

Roche announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Nov

PBR

Petrobras

$14.44

-0.09 (-0.62%)

11:42
09/20/19
09/20
11:42
09/20/19
11:42
Periodicals
Petrobras suffers increase in fuel theft from pipelines, Reuters reports »

Petrobras is confronting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROKU

Roku

$116.20

-17.51 (-13.10%)

11:40
09/20/19
09/20
11:40
09/20/19
11:40
Options
Roku leads single stock option volume with over 250K contracts in 90 minutes »

Roku leads single stock…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:40
09/20/19
09/20
11:40
09/20/19
11:40
General news
More from Rosengren: he reiterated his dissent »

More from Rosengren: he…

RYAAY

Ryanair

$62.91

0.43 (0.69%)

11:38
09/20/19
09/20
11:38
09/20/19
11:38
Hot Stocks
Ryanair U.K. pilots union cancels five further strike days »

The British Airline…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDR

McDermott

$2.74

1.16 (73.42%)

11:35
09/20/19
09/20
11:35
09/20/19
11:35
Recommendations
McDermott analyst commentary  »

McDermott's plans to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

VAL

Valaris

$6.76

-0.01 (-0.15%)

11:35
09/20/19
09/20
11:35
09/20/19
11:35
Options
Valaris Plc put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:35
09/20/19
09/20
11:35
09/20/19
11:35
General news
NY Fed announced it will conduct daily repo operations »

NY Fed announced it will…

ADBE

Adobe

$278.77

-2.44 (-0.87%)

11:28
09/20/19
09/20
11:28
09/20/19
11:28
Hot Stocks
Lucas announces departure from Adobe and Marketo »

Steve Lucas announced in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 27

    Oct

TELL

Tellurian

$8.75

0.165 (1.92%)

11:25
09/20/19
09/20
11:25
09/20/19
11:25
Options
Tellurian call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACHV

Achieve Life Sciences

$2.21

0.095 (4.49%)

11:25
09/20/19
09/20
11:25
09/20/19
11:25
Conference/Events
Achieve Life Sciences to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 24

    Sep

FB

Facebook

$191.40

1.25 (0.66%)

, SNAP

Snap

$16.91

0.04 (0.24%)

11:25
09/20/19
09/20
11:25
09/20/19
11:25
Conference/Events
FBN Securities Tech/Internet analyst to hold a group luncheon »

technology and Internet…

FB

Facebook

$191.40

1.25 (0.66%)

SNAP

Snap

$16.91

0.04 (0.24%)

TWTR

Twitter

$43.65

0.71 (1.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 24

    Sep

  • 27

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.